Drug – bio-affecting and body treating compositions – Enzyme or coenzyme containing – Hydrolases
Patent
1979-08-20
1981-08-25
Phillips, Delbert R.
Drug, bio-affecting and body treating compositions
Enzyme or coenzyme containing
Hydrolases
2601125R, 260112R, 435184, 435217, 435216, A61K 3748, C07C10352, C07G 700, C12N 970, C12N 968, C12N 999
Patent
active
042859328
ABSTRACT:
A pharmaceutical composition which comprises a pharmaceutically acceptable carrier together with an in vivo fibrinolytic enzyme as defined herein wherein the catalytic site essential for fibrinolytic activity is blocked by a group which is removable by hydrolysis at a rate such that the pseudo-first order rate constant for hydrolysis is in the range 10.sup.-6 sec.sup.-1 to 10.sup.-3 sec.sup.-1 in isotonic aqueous media at pH 7.4 at 37.degree. C.; is useful in the treatment of venous thrombosis.
REFERENCES:
C. Malen, et al., Chem. Abstr. vol. 76, 1972, p. 85810f.
Z. Skrzydlewski, et al., Chem. Abstr. vol. 78, 1973, p. 699v.
A. J. Baillie, et al., Chem. Abstr. vol. 78, 1973, p. 53467z.
L. Nanninga, Chem. Abstr. vol. 82, 1975, p. 106973c.
T. Chase, Jr., et al., Biochemistry 8, 1969, pp. 2212-2224.
Beecham Group Limited
Phillips Delbert R.
LandOfFree
Enzyme derivatives for use in the treatment of venous thrombosis does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Enzyme derivatives for use in the treatment of venous thrombosis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Enzyme derivatives for use in the treatment of venous thrombosis will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1158334